Evaluation of the anti-tumour efficacy of Abemaciclib, a dual CDK4/6 inhibitor, both as a single agent and combined with radiotherapy in Medulloblastoma (2018)

Dr Laura Genovesi

Honorary Senior Research Fellow

Institute for Molecular Bioscience